IRIS
CANONICA, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.843
AS - Asia 15.114
EU - Europa 7.387
SA - Sud America 6.179
AF - Africa 994
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 50.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.134
SG - Singapore 8.579
BR - Brasile 4.982
IT - Italia 3.073
VN - Vietnam 2.497
CN - Cina 2.017
FI - Finlandia 975
IE - Irlanda 842
NG - Nigeria 601
DE - Germania 550
AR - Argentina 502
FR - Francia 472
GB - Regno Unito 383
CA - Canada 374
NL - Olanda 312
IN - India 287
HK - Hong Kong 257
TR - Turchia 243
BD - Bangladesh 230
EC - Ecuador 226
ID - Indonesia 216
RU - Federazione Russa 206
MX - Messico 177
CO - Colombia 133
IQ - Iraq 129
ZA - Sudafrica 126
SE - Svezia 122
UA - Ucraina 96
IL - Israele 94
PY - Paraguay 93
PK - Pakistan 77
CL - Cile 74
VE - Venezuela 69
PL - Polonia 63
SA - Arabia Saudita 60
UZ - Uzbekistan 56
ES - Italia 54
EG - Egitto 47
MA - Marocco 46
KE - Kenya 44
UY - Uruguay 41
TN - Tunisia 40
JP - Giappone 38
PE - Perù 35
DZ - Algeria 31
AU - Australia 29
BE - Belgio 29
KR - Corea 27
NP - Nepal 27
PH - Filippine 26
AZ - Azerbaigian 24
JO - Giordania 24
DO - Repubblica Dominicana 23
JM - Giamaica 23
RO - Romania 23
AE - Emirati Arabi Uniti 22
BO - Bolivia 21
CZ - Repubblica Ceca 21
IR - Iran 20
KZ - Kazakistan 20
AT - Austria 19
ET - Etiopia 18
AL - Albania 17
MY - Malesia 17
TT - Trinidad e Tobago 16
OM - Oman 15
BG - Bulgaria 14
CR - Costa Rica 14
HN - Honduras 14
KG - Kirghizistan 14
PA - Panama 14
GR - Grecia 13
LT - Lituania 13
SV - El Salvador 13
PT - Portogallo 12
GT - Guatemala 11
SN - Senegal 11
SY - Repubblica araba siriana 11
LB - Libano 10
AM - Armenia 9
GE - Georgia 9
NI - Nicaragua 9
PR - Porto Rico 9
PS - Palestinian Territory 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BA - Bosnia-Erzegovina 8
CH - Svizzera 8
KW - Kuwait 8
MN - Mongolia 8
RS - Serbia 8
BH - Bahrain 7
MD - Moldavia 7
AO - Angola 6
DK - Danimarca 6
HR - Croazia 6
LV - Lettonia 6
TH - Thailandia 6
TW - Taiwan 6
BW - Botswana 5
CI - Costa d'Avorio 5
Totale 50.481
Salva come PNG Salva come JPEG
Città #
Wilmington 4.532
Singapore 3.382
San Mateo 1.696
The Dalles 1.555
Milan 1.343
Dallas 1.129
Ann Arbor 1.032
Shanghai 1.009
Helsinki 972
Ashburn 969
Ho Chi Minh City 915
Leawood 866
Dublin 837
Lawrence 775
Princeton 771
Rome 627
Benin City 594
Fairfield 578
Hanoi 523
Woodbridge 516
Chandler 488
San Jose 419
São Paulo 415
Paris 403
Beijing 308
New York 279
Amsterdam 271
Hong Kong 239
Santa Clara 209
Los Angeles 205
London 194
Toronto 182
Kocaeli 168
Orem 153
Rio de Janeiro 145
Falkenstein 141
Boardman 110
Haiphong 105
Norwalk 100
Buffalo 96
Figino 96
Da Nang 94
Turin 92
Brasília 88
Curitiba 88
Guayaquil 87
Belo Horizonte 84
Porto Alegre 75
Naples 70
Chennai 69
Campinas 66
Biên Hòa 65
Guarulhos 62
Chicago 60
Manchester 57
Montreal 57
Dhaka 56
Quito 56
Phoenix 54
Salvador 52
Tashkent 51
Warsaw 50
Johannesburg 47
Charlotte 46
Ellicott City 46
Buenos Aires 45
Hải Dương 44
Philadelphia 44
Seattle 44
Asunción 43
Monmouth Junction 43
Moscow 43
Jakarta 41
Mumbai 41
Bologna 40
Frankfurt am Main 39
Ninh Bình 39
Florence 38
Montevideo 37
Ribeirão Preto 37
Baghdad 36
Brooklyn 36
Atlanta 35
Nairobi 35
Sorocaba 35
Altamonte Springs 34
Fortaleza 34
Goiânia 34
Mexico City 34
Thái Bình 34
Houston 33
São Bernardo do Campo 33
Birmingham 32
Can Tho 32
Thái Nguyên 32
Genoa 31
Bogotá 30
Manaus 29
Medellín 29
Phủ Lý 29
Totale 32.194
Salva come PNG Salva come JPEG
Nome #
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco 746
Quality of life and polysensitization in young men with intermittent asthma 216
A critical appraisal on AIT in childhood asthma. 155
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis 139
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 134
Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis--a randomized controlled study 132
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 131
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 130
An academic allergy unit during COVID-19 pandemic in Italy. 117
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 117
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study 115
Pidotimod: The state of art 110
A Charter to Improve Patient Care in Severe Asthma 109
A new protocol for specific oral tolerance induction in children with IgE-mediated cow's milk allergy 106
Work productivity in rhinitis using cell phones: The MASK pilot study 106
A multi-allergen ELISA screening method. Comparison with Pharmacia CAP system and Phazet skin prick test 104
30 Years Of Sublingual Immunotherapy 104
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 103
A 4-year trial of tiotropium in chronic obstructive pulmonary disease 103
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 103
The Severe Asthma Network in Italy: Findings and Perspectives 102
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 102
Comparison of the colony forming capacities of human T lymphocyte subpopulations 101
2019 ARIA Care pathways for allergen immunotherapy 101
60Co therapy as an "allergic breakthrough" in a case of food allergy 100
Treatable traits in chronic rhinosinusitis with nasal polyps 100
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 94
A model of allergen-driven human airway contraction:beta2 pathway dysfunction without cytokine involvement 93
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe 93
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA) 91
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes 91
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) 91
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress 91
[GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases] 91
Strategies to reduce corticosteroid-related adverse events in asthma 90
A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects 89
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 88
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 87
Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study 87
Clinical Characteristics Associated with Conjunctival Inflammation in Allergic Rhinoconjunctivitis 87
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper 86
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice 86
Microarray Immunodiagnostics for Aeroallergens 85
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis 85
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 85
New drugs in early-stage clinical trials for allergic rhinitis 84
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 84
International consensus on allergy immunotherapy 84
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL) 84
Role of leukotrienes receptors antagonista in the management of mild-to-moderate asthma 84
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 84
Pilot study of mobile phone technology in allergic rhinitis in European countries: The MASK-rhinitis study 84
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life 84
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 83
[Our experience in the treatment of bronchial asthma and asthmatic bronchitis with salbutamol] 83
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update 82
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria 82
Do Asthmatic Patients and Their Physicians Agree on the Presence and Severity of Allergic Rhinitis? 82
Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva allergen challenge 82
Cytokines and airways: recent insights and therapeutic implications 82
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics 81
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma 81
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials 81
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy 80
EAACI guidelines on allergen immunotherapy: Executive statement 80
Meta analysis of SLIT in children 80
[ICAM-1 and allergic inflammation] 80
A survey of the burden of allergic rhinitis in Europe 80
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU 80
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 79
Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions 79
Sublingual immunotherapy: update 2006 79
EAACI/GA2LEN/EDF guideline: management of urticaria 79
Umeclidinium for the treatment of uncontrolled asthma 79
Escaping the trap of allergic rhinitis. 78
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs 78
International Severe Asthma Registry (ISAR): The Story so Far 78
Assessing biomarkers in a real-world severe asthma study (ARIETTA) 78
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision 78
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 78
A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis 78
Characteristics of patients with seasonal allergic rhinitis and concomitant asthma 78
Adherence to asthma treatments: 'We know, we intend, we advocate' 78
Cetirizine treatment of allergic cough in children with pollen allergy 78
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 78
Allergen Immunotherapy (AIT): A prototype of Precision Medicine 77
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters 77
[Anti-leukotriene agents: rationale for and prospects of use] 77
General strategy for the management of bronchial asthma in pregnancy 77
The relationship between allergen immunotherapy and omalizumab for treating asthma 76
Efficacy and Safety of High ICS Dose Fixed-Combination ICS/LABA/LAMA pMDI Compared with ICS/LABA and ICS/LABA plus LAMA in Patients with Uncontrolled Asthma: The TRIGGER Study 76
Turkish Version of the Chronic Urticaria Quality of Life Questionnaire: Cultural Adaptation, Assessment of Reliability and Validity 76
[Immunotherapy in Latin America. From the past to the future] 76
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 76
The safety of allergen specific sublingual immunotherapy 76
Molecole di adesione: struttura, funzione e ruolo fisiopatologico nelle malattie infiammatorie 75
Immunologic and clinical evaluation of a 12-month course of specific immunotherapy 75
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria 75
Dupilumab Improves Upper and Lower Airway Outcome Measures in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma: Pooled Results from the SINUS-24 and SINUS-52 Phase 3 Studies 75
Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma 75
Totale 9.739
Salva come PNG Salva come JPEG
Categoria #
all - tutte 361.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 361.326
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.070 117 7 50 781 15 17 130 610 304 295 680 64
2022/20234.261 1.617 85 825 139 101 86 19 93 282 774 218 22
2023/20243.395 168 387 769 31 32 141 119 116 50 34 638 910
2024/20255.980 79 34 38 53 56 786 211 381 704 1.955 748 935
2025/202624.138 2.647 1.455 2.593 5.006 661 506 3.665 1.334 1.353 1.101 650 3.167
2026/20271.722 1.722 0 0 0 0 0 0 0 0 0 0 0
Totale 51.516